# Psychedelic Medicine SPV

Psychedelic Medicine SPV is an Asset Manager based in San Juan, United States.

## Overview

- **Organization type:** Asset Manager
- **Headquarters:** San Juan, United States
- **Region:** North America
- **Address:** San Juan, Puerto Rico, United States
- **Assets under management:** Undisclosed

## Regulatory record

- **Reports private funds:** No

## About

Psychedelic Medicine SPV is a London- and San Juan-based investment vehicle focused on the emerging psychedelic therapeutics sector. The strategy centers on clinical-stage assets with FDA breakthrough-therapy status — a designation that accelerates regulatory review. The firm targets companies advancing through Phase II and III trials, with an emphasis on post-traumatic stress disorder (PTSD) and treatment-resistant depression. Known exposures in the space include firms like Compass Pathways, which received breakthrough status for psilocybin in depression, and MAPS Public Benefit Corporation, which completed Phase III trials for MDMA-assisted therapy in PTSD. Geographic focus spans North America and Europe, where regulatory frameworks for psychedelic therapies are evolving. Deployment scale and team size are not publicly disclosed. The firm maintains offices in London, San Juan, New York, Lewes (UK), and Brisbane — a geographically distributed footprint unusual for a single-purpose vehicle. No philanthropic foundations or adjacent vehicles are confirmed in public records. In the absence of recent operational events, the firm's posture remains anchored to the regulatory calendar of psychedelic drug approvals. The structural differentiator is the SPV form itself — a finite-life, single-thesis vehicle allowing concentrated bets on a narrow regulatory catalyst. This contrasts with evergreen funds or diversified healthcare managers, aligning capital deployment with discrete drug-approval milestones. Governance and succession structures are not publicly documented.

## Sectors

- Digital Health
- Healthcare Services

## Offices

- London, United Kingdom
- Lewes, United Kingdom
- New York, United States
- Brisbane, Australia

## Questions

### What is the Psychedelic Medicine SPV's core investment thesis?

The SPV targets clinical-stage companies developing psychedelic-assisted therapies for mental health conditions, particularly PTSD and treatment-resistant depression. It focuses on assets with FDA breakthrough-therapy status, which offers expedited development and review. The strategy is a binary bet on regulatory approval of drugs like MDMA and psilocybin.

### Which regulatory approvals is the SPV most tied to?

The firm's performance hinges on FDA decisions for MDMA-assisted therapy (backed by MAPS PBC) and psilocybin treatments developed by companies like Compass Pathways. The DEA's rescheduling of psychedelics also materially impacts the investment climate. European Medicines Agency decisions for the same compounds create additional catalyst points.

### How does the SPV structure differ from a healthcare focused venture capital fund?

As a special purpose vehicle, Psychedelic Medicine SPV has a finite lifespan and a single-company or single-sector mandate — it does not recycle capital into new strategies. This contrasts with evergreen venture funds that can invest across stages and sectors. The SPV model aligns investor returns directly with regulatory milestones and exit events.

### What are the primary risk factors for an investment in this vehicle?

The key risks include FDA non-approval, adverse trial results, DEA scheduling shifts, and public stigma remaining high enough to limit commercialization. The concentrated single-sector approach means these are correlated risks — a regulatory setback for one compound affects the entire thesis. Liquidity risk is also elevated given the absence of a secondary market for most positions.

## Related profiles

- [BWC Group](https://altss.com/profile/bwc-group)
- [Stem](https://altss.com/profile/stem)

---

Last updated: 2026-08-11T02:43:31.692Z

Canonical page: https://altss.com/profile/psychedelic-medicine-spv

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology